Health2Tech

RxE2 CEO Gerald Finken talks about using pharmacists and AI to redesign clinical trials. We discuss post-pandemic research, patient access, and how pharma companies adopt new trial models.

Former speech pathologist Bailey Morgan explains how her clinical background shapes her role as a Clinical Product Specialist. We dive into selling to health systems, long sales cycles, and AI adoption in care.

OBG Access founder Nish Varma shares his journey from finance to maternal health innovation. We talk regulations, entering new markets, childbirth safety devices, and advice for MedTech founders.

FINN Partners’ Ritesh Patel reflects on decades in digital health, from early pilots to today’s hype cycle. We explore value-based care, rural health equity, and whether tech is actually fixing the system.

Advisor and venture studio leader Vadim Gordin argues why now is still a great time to build in digital health. We discuss founder mistakes, integration challenges, and what separates standout teams from the rest.

Infinitus founder Ankit Jain explains how AI can automate healthcare workflows and where the real value lies. We talk call automation, job impact, VC attitudes, and the future of AI in health operations.

Sergei Polevikov offers an unfiltered take on US healthcare, EHRs, primary care, VC behavior, and AI hype. This is a frank conversation about what’s broken, what’s promising, and what founders should avoid.

Entrepreneur Lisa Voronkova shares lessons from building medical and wellness devices. We cover accelerator programs, taking a device from idea to market, and the realities of MedTech entrepreneurship.

Advisor Amir Lahav talks about how pharma is embracing digital health, from RPM devices to new kinds of clinical trials. We explore startup–pharma partnerships and what has really changed post-COVID.

Investor and political strategist Bradley Tusk explains how regulation can both block and unlock innovation in healthcare. We cover startup selection, AI in health, and how policy and tech collide.